Correlation Between Ventyx Biosciences and Ascendis Pharma
Can any of the company-specific risk be diversified away by investing in both Ventyx Biosciences and Ascendis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ventyx Biosciences and Ascendis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ventyx Biosciences and Ascendis Pharma AS, you can compare the effects of market volatilities on Ventyx Biosciences and Ascendis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ventyx Biosciences with a short position of Ascendis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ventyx Biosciences and Ascendis Pharma.
Diversification Opportunities for Ventyx Biosciences and Ascendis Pharma
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Ventyx and Ascendis is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Ventyx Biosciences and Ascendis Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascendis Pharma AS and Ventyx Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ventyx Biosciences are associated (or correlated) with Ascendis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascendis Pharma AS has no effect on the direction of Ventyx Biosciences i.e., Ventyx Biosciences and Ascendis Pharma go up and down completely randomly.
Pair Corralation between Ventyx Biosciences and Ascendis Pharma
Given the investment horizon of 90 days Ventyx Biosciences is expected to under-perform the Ascendis Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Ventyx Biosciences is 1.01 times less risky than Ascendis Pharma. The stock trades about -0.18 of its potential returns per unit of risk. The Ascendis Pharma AS is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 12,813 in Ascendis Pharma AS on November 18, 2024 and sell it today you would earn a total of 1,595 from holding Ascendis Pharma AS or generate 12.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ventyx Biosciences vs. Ascendis Pharma AS
Performance |
| Timeline |
| Ventyx Biosciences |
| Ascendis Pharma AS |
Ventyx Biosciences and Ascendis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ventyx Biosciences and Ascendis Pharma
The main advantage of trading using opposite Ventyx Biosciences and Ascendis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ventyx Biosciences position performs unexpectedly, Ascendis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascendis Pharma will offset losses from the drop in Ascendis Pharma's long position.| Ventyx Biosciences vs. Arcellx | Ventyx Biosciences vs. Immunocore Holdings | Ventyx Biosciences vs. Vaxcyte | Ventyx Biosciences vs. Nuvalent |
| Ascendis Pharma vs. Apellis Pharmaceuticals | Ascendis Pharma vs. Akero Therapeutics | Ascendis Pharma vs. Blueprint Medicines Corp | Ascendis Pharma vs. Replimune Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |